610 related articles for article (PubMed ID: 19493409)
1. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
[TBL] [Abstract][Full Text] [Related]
2. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
Chok KS; Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
Arch Surg; 2006 Dec; 141(12):1231-6. PubMed ID: 17178966
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
[TBL] [Abstract][Full Text] [Related]
5. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
6. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
10. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD
Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
[TBL] [Abstract][Full Text] [Related]
11. [Comparision of different interventional therapies for primary liver cancer].
Liu YM; Qin H; Wang CB; Fang XH; Ma QY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
13. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
[TBL] [Abstract][Full Text] [Related]
16. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
